Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gensci Regeneration Sciences Inc. (GNS) -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (182)	7/4/1999 2:40:00 AM
From: Andras	Read Replies (3) \| Respond to of 225

Edward I think that your point about expenses is a fair comment..BUT companies cannot shrink to greatness..ultimately it is earnings that drive value and Gensci has huge growth in sales and earnings will come..don't forget it still has a large pure research division.osteopharm that's a drain the fact is that it has obviously demonstrated technology and increasing market acceptance... as for the share price..that too will come with greater exposure etc. analysts tend to follow larger cap stocks where institutions are potential buyers and sellers..Gensci will be recognized..its a question of time happy investing, andras